instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'DACARBAZINE'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | ABVD REGIMEN | DrugDosageText | CC BY | 33816231 | 19,484,292 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | GDP REGIMEN | DrugDosageText | CC BY | 33816231 | 19,484,292 | 2021 |
What was the dosage of drug 'DOXORUBICIN'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | ABVD REGIMEN | DrugDosageText | CC BY | 33816231 | 19,484,292 | 2021 |
What was the dosage of drug 'EPIRUBICIN'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | IVE REGIMEN AS SALVAGE CHEMOTHERAPY | DrugDosageText | CC BY | 33816231 | 19,484,292 | 2021 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | 400 MG/KG | DrugDosageText | CC BY | 33816231 | 19,448,979 | 2021 |
What was the dosage of drug 'IFOSFAMIDE'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | IVE REGIMEN AS SALVAGE CHEMOTHERAPY | DrugDosageText | CC BY | 33816231 | 19,484,292 | 2021 |
What was the dosage of drug 'VINBLASTINE'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | ABVD REGIMEN | DrugDosageText | CC BY | 33816231 | 19,484,292 | 2021 |
What was the outcome of reaction 'Acute respiratory distress syndrome'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Fatal | ReactionOutcome | CC BY | 33816231 | 19,453,188 | 2021 |
What was the outcome of reaction 'COVID-19 pneumonia'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Fatal | ReactionOutcome | CC BY | 33816231 | 19,484,292 | 2021 |
What was the outcome of reaction 'COVID-19'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Fatal | ReactionOutcome | CC BY | 33816231 | 19,484,292 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Not recovered | ReactionOutcome | CC BY | 33816231 | 19,484,292 | 2021 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Fatal | ReactionOutcome | CC BY | 33816231 | 19,448,979 | 2021 |
What was the outcome of reaction 'Epstein-Barr viraemia'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Recovered | ReactionOutcome | CC BY | 33816231 | 19,453,188 | 2021 |
What was the outcome of reaction 'Lymphopenia'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Not recovered | ReactionOutcome | CC BY | 33816231 | 19,484,292 | 2021 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Fatal | ReactionOutcome | CC BY | 33816231 | 19,160,636 | 2021 |
What was the outcome of reaction 'Off label use'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Fatal | ReactionOutcome | CC BY | 33816231 | 19,448,979 | 2021 |
What was the outcome of reaction 'Post transplant lymphoproliferative disorder'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Recovered | ReactionOutcome | CC BY | 33816231 | 19,453,188 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes f... | Fatal | ReactionOutcome | CC BY | 33816231 | 19,484,292 | 2021 |
What is the weight of the patient? | Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients.
Rationale/Objectives: A human coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19) outbreak worldwide. There is an urgent need to develop new interventions to suppress the excessive immune r... | 118.75 kg. | Weight | CC BY | 33816515 | 19,630,558 | 2021 |
What was the administration route of drug 'RIBAVIRIN'? | Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients.
Rationale/Objectives: A human coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19) outbreak worldwide. There is an urgent need to develop new interventions to suppress the excessive immune r... | Oral | DrugAdministrationRoute | CC BY | 33816515 | 19,630,558 | 2021 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients.
Rationale/Objectives: A human coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19) outbreak worldwide. There is an urgent need to develop new interventions to suppress the excessive immune r... | UNK, 10 DAYS COURSE | DrugDosageText | CC BY | 33816515 | 19,630,558 | 2021 |
What was the dosage of drug 'RIBAVIRIN'? | Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients.
Rationale/Objectives: A human coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19) outbreak worldwide. There is an urgent need to develop new interventions to suppress the excessive immune r... | UNK, THREE DOSES | DrugDosageText | CC BY | 33816515 | 19,630,558 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cystitis haemorrhagic'. | Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis.... | CYCLOPHOSPHAMIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, SULFAMETHOXAZOLE, TACROLIMUS | DrugsGivenReaction | CC BY | 33816524 | 19,698,794 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection reactivation'. | Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis.... | CYCLOPHOSPHAMIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, SULFAMETHOXAZOLE, TACROLIMUS | DrugsGivenReaction | CC BY | 33816524 | 19,698,946 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis.... | CYCLOPHOSPHAMIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, SULFAMETHOXAZOLE, TACROLIMUS | DrugsGivenReaction | CC BY | 33816524 | 19,698,946 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transplant failure'. | Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis.... | CYCLOPHOSPHAMIDE, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, SULFAMETHOXAZOLE, TACROLIMUS | DrugsGivenReaction | CC BY | 33816524 | 19,698,946 | 2021 |
What was the administration route of drug 'TACROLIMUS'? | Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis.... | Oral | DrugAdministrationRoute | CC BY | 33816524 | 19,698,779 | 2021 |
What was the outcome of reaction 'Cystitis haemorrhagic'? | Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis.... | Recovering | ReactionOutcome | CC BY | 33816524 | 19,698,794 | 2021 |
What was the outcome of reaction 'Pancytopenia'? | Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis.... | Recovered | ReactionOutcome | CC BY | 33816524 | 19,698,946 | 2021 |
What was the outcome of reaction 'Transplant failure'? | Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.
The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis.... | Recovered | ReactionOutcome | CC BY | 33816524 | 19,698,946 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | HERBALS, ITRACONAZOLE, OSIMERTINIB | DrugsGivenReaction | CC BY | 33816581 | 19,609,339 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | HERBALS, ITRACONAZOLE, OSIMERTINIB | DrugsGivenReaction | CC BY | 33816581 | 19,609,339 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | HERBALS, ITRACONAZOLE, OSIMERTINIB | DrugsGivenReaction | CC BY | 33816581 | 19,609,339 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | HERBALS, ITRACONAZOLE, OSIMERTINIB | DrugsGivenReaction | CC BY | 33816581 | 19,609,339 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Loss of consciousness'. | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | HERBALS, ITRACONAZOLE, OSIMERTINIB | DrugsGivenReaction | CC BY | 33816581 | 19,609,339 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial ischaemia'. | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | HERBALS, ITRACONAZOLE, OSIMERTINIB | DrugsGivenReaction | CC BY | 33816581 | 19,609,339 | 2021 |
What was the administration route of drug 'ITRACONAZOLE'? | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | Oral | DrugAdministrationRoute | CC BY | 33816581 | 19,609,339 | 2021 |
What was the administration route of drug 'OSIMERTINIB'? | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | Oral | DrugAdministrationRoute | CC BY | 33816581 | 19,609,339 | 2021 |
What was the outcome of reaction 'Cardiac arrest'? | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | Recovered | ReactionOutcome | CC BY | 33816581 | 19,609,339 | 2021 |
What was the outcome of reaction 'Drug interaction'? | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | Recovered | ReactionOutcome | CC BY | 33816581 | 19,609,339 | 2021 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | Recovered | ReactionOutcome | CC BY | 33816581 | 19,609,339 | 2021 |
What was the outcome of reaction 'Hypokalaemia'? | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | Recovered | ReactionOutcome | CC BY | 33816581 | 19,609,339 | 2021 |
What was the outcome of reaction 'Loss of consciousness'? | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | Recovered | ReactionOutcome | CC BY | 33816581 | 19,609,339 | 2021 |
What was the outcome of reaction 'Myocardial ischaemia'? | Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib.
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (E... | Recovered | ReactionOutcome | CC BY | 33816581 | 19,609,339 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | CARBIDOPA\ENTACAPONE\LEVODOPA, ROPINIROLE HYDROCHLORIDE, SAFINAMIDE | DrugsGivenReaction | CC BY | 33816681 | 19,173,916 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Apathy'. | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | CARBIDOPA\ENTACAPONE\LEVODOPA, ROPINIROLE HYDROCHLORIDE, SAFINAMIDE | DrugsGivenReaction | CC BY | 33816681 | 19,173,916 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depressive symptom'. | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | CARBIDOPA\ENTACAPONE\LEVODOPA, ROPINIROLE HYDROCHLORIDE, SAFINAMIDE | DrugsGivenReaction | CC BY | 33816681 | 19,173,916 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypersexuality'. | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | PRAMIPEXOLE, RASAGILINE | DrugsGivenReaction | CC BY | 33816681 | 19,183,583 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Libido increased'. | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | CARBIDOPA\ENTACAPONE\LEVODOPA, ROPINIROLE HYDROCHLORIDE, SAFINAMIDE | DrugsGivenReaction | CC BY | 33816681 | 19,173,916 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Personality change'. | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | PRAMIPEXOLE, RASAGILINE | DrugsGivenReaction | CC BY | 33816681 | 19,183,583 | 2021-04 |
What was the administration route of drug 'PRAMIPEXOLE'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Oral | DrugAdministrationRoute | CC BY | 33816681 | 19,187,778 | 2021-04 |
What was the dosage of drug 'CARBIDOPA\ENTACAPONE\LEVODOPA'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | 675/168.5/1000 MG DISTRIBUTED IN FIVE DOSES | DrugDosageText | CC BY | 33816681 | 19,173,916 | 2021-04 |
What was the dosage of drug 'RASAGILINE'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | 2 mg (milligrams). | DrugDosage | CC BY | 33816681 | 19,183,583 | 2021-04 |
What was the dosage of drug 'SAFINAMIDE'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | 100 mg (milligrams). | DrugDosage | CC BY | 33816681 | 19,173,916 | 2021-04 |
What was the outcome of reaction 'Abnormal behaviour'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Recovered | ReactionOutcome | CC BY | 33816681 | 19,173,916 | 2021-04 |
What was the outcome of reaction 'Anxiety'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Recovering | ReactionOutcome | CC BY | 33816681 | 19,173,916 | 2021-04 |
What was the outcome of reaction 'Apathy'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Recovering | ReactionOutcome | CC BY | 33816681 | 19,173,916 | 2021-04 |
What was the outcome of reaction 'Depressive symptom'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Recovering | ReactionOutcome | CC BY | 33816681 | 19,173,916 | 2021-04 |
What was the outcome of reaction 'Hypersexuality'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Recovered | ReactionOutcome | CC BY | 33816681 | 19,183,583 | 2021-04 |
What was the outcome of reaction 'Hypomania'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Recovered | ReactionOutcome | CC BY | 33816681 | 19,173,916 | 2021-04 |
What was the outcome of reaction 'Libido increased'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Recovered | ReactionOutcome | CC BY | 33816681 | 19,173,916 | 2021-04 |
What was the outcome of reaction 'Personality change'? | Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review.
Impulse control disorders (ICDs) are a frequent side effect of dopamine replacement therapy (DRT) in Parkinson's disease (PD). Reckless generosity might expand the spectrum of known ICDs.
Over 18 months, we encountered three PD ... | Recovered | ReactionOutcome | CC BY | 33816681 | 19,183,583 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ulcerative'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISONE, SELENIUM, TEPROTUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,169,923 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deafness'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISONE, SELENIUM, TEPROTUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,169,923 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISONE, SELENIUM | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,163,016 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISONE, SELENIUM | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,163,016 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISOLONE, SELENIUM | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,401,948 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endocrine ophthalmopathy'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISONE, SELENIUM | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,163,016 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematochezia'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISONE, SELENIUM, TEPROTUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,169,923 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle spasms'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISONE, SELENIUM, TEPROTUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,169,923 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | METHIMAZOLE, PREDNISONE, SELENIUM, TEPROTUMUMAB | DrugsGivenReaction | CC BY-NC-ND | 33817409 | 19,169,923 | 2021-06 |
What was the administration route of drug 'METHIMAZOLE'? | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33817409 | 19,163,016 | 2021-06 |
What was the administration route of drug 'PREDNISOLONE'? | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33817409 | 19,401,948 | 2021-06 |
What was the administration route of drug 'PREDNISONE'? | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33817409 | 19,163,016 | 2021-06 |
What was the administration route of drug 'TEPROTUMUMAB'? | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | Other | DrugAdministrationRoute | CC BY-NC-ND | 33817409 | 19,169,923 | 2021-06 |
What was the dosage of drug 'PREDNISONE'? | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | 30 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33817409 | 19,163,016 | 2021-06 |
What was the dosage of drug 'SELENIUM'? | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | 200 µg (micrograms). | DrugDosage | CC BY-NC-ND | 33817409 | 19,163,016 | 2021-06 |
What was the outcome of reaction 'Deafness'? | A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.
A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagn... | Recovered | ReactionOutcome | CC BY-NC-ND | 33817409 | 19,169,923 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphopenia'. | Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions.
BACKGROUND
Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF) treat... | DIMETHYL FUMARATE | DrugsGivenReaction | CC BY | 33820529 | 19,149,422 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions.
BACKGROUND
Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF) treat... | DIMETHYL FUMARATE, MIRTAZAPINE | DrugsGivenReaction | CC BY | 33820529 | 19,472,390 | 2021-04-05 |
What was the administration route of drug 'DIMETHYL FUMARATE'? | Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions.
BACKGROUND
Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF) treat... | Oral | DrugAdministrationRoute | CC BY | 33820529 | 19,149,422 | 2021-04-05 |
What was the outcome of reaction 'Lymphopenia'? | Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions.
BACKGROUND
Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF) treat... | Recovered | ReactionOutcome | CC BY | 33820529 | 19,149,422 | 2021-04-05 |
What was the outcome of reaction 'Progressive multifocal leukoencephalopathy'? | Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions.
BACKGROUND
Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF) treat... | Recovered | ReactionOutcome | CC BY | 33820529 | 19,149,422 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercapnia'. | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | MORPHINE SULFATE | DrugsGivenReaction | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | MORPHINE SULFATE | DrugsGivenReaction | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | MORPHINE SULFATE | DrugsGivenReaction | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory acidosis'. | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | MORPHINE SULFATE | DrugsGivenReaction | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory rate decreased'. | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | MORPHINE SULFATE | DrugsGivenReaction | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stupor'. | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | MORPHINE SULFATE | DrugsGivenReaction | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
What was the administration route of drug 'MORPHINE SULFATE'? | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | Intrathecal | DrugAdministrationRoute | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
What was the outcome of reaction 'Hypercapnia'? | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | Recovered | ReactionOutcome | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
What was the outcome of reaction 'Hypoxia'? | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | Recovered | ReactionOutcome | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
What was the outcome of reaction 'Overdose'? | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | Recovered | ReactionOutcome | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
What was the outcome of reaction 'Respiratory acidosis'? | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | Recovered | ReactionOutcome | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
What was the outcome of reaction 'Respiratory rate decreased'? | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | Recovered | ReactionOutcome | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
What was the outcome of reaction 'Stupor'? | Morphine overinfusion of intrathecal drug administration system under magnetic resonance evaluation for the diagnosis of stroke: a case report.
BACKGROUND
Until recently, it is generally considered safe to perform magnetic resonance imaging (MRI) in patients with an intrathecal drug administration system (ITDAS) device... | Recovered | ReactionOutcome | CC BY | 33820539 | 19,190,500 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug reaction with eosinophilia and systemic symptoms'. | DRESS induced by amoxicillin-clavulanate in two pediatric patients confirmed by lymphocyte toxicity assay.
BACKGROUND
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but serious delayed hypersensitivity reaction that can be caused by antibiotic exposure. The reaction typically develops in 2 to 6... | AMOXICILLIN\CLAVULANIC ACID | DrugsGivenReaction | CC BY | 33820548 | 19,217,794 | 2021-04-05 |
What was the outcome of reaction 'Drug reaction with eosinophilia and systemic symptoms'? | DRESS induced by amoxicillin-clavulanate in two pediatric patients confirmed by lymphocyte toxicity assay.
BACKGROUND
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but serious delayed hypersensitivity reaction that can be caused by antibiotic exposure. The reaction typically develops in 2 to 6... | Recovered | ReactionOutcome | CC BY | 33820548 | 19,217,794 | 2021-04-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Binge eating'. | Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia.
Eating disorders, like binge eating, have a strong association with schizophrenia. Illness characteristics like disordered eating, cognition, and behavior can lead to eating disorders. Previous research highlighted the neurobiologica... | AMISULPRIDE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33820877 | 19,840,316 | 2021-06-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight increased'. | Obesogenic Behavior and Binge Eating Disorder in an Elderly Female with Schizophrenia.
Eating disorders, like binge eating, have a strong association with schizophrenia. Illness characteristics like disordered eating, cognition, and behavior can lead to eating disorders. Previous research highlighted the neurobiologica... | AMISULPRIDE, RISPERIDONE | DrugsGivenReaction | CC BY-NC | 33820877 | 19,840,316 | 2021-06-30 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.